Carpal tunnel syndrome — supplement protocol and what actually works
Carpal tunnel syndrome is one of the most consistently overhyped supplement targets. The supplement marketing — particularly around high-dose vitamin B6 — outruns the trial evidence. The honest read: night splinting, ergonomic correction, and (when indicated) corticosteroid injection or surgical release are the interventions that change carpal tunnel outcomes. Supplements at modest doses are an adjunct, not a treatment.
Where the evidence sits
Vitamin B6 (P-5-P) — at low dose, in B6 deficiency or insufficiency
25–50 mg/day pyridoxal-5-phosphate (P5P), not pyridoxine, for 8–12 weeks; reassess
The original Ellis 1979 case series claimed high-dose B6 (100–200 mg/day) improved CTS symptoms. Modern systematic reviews (Aufiero 2004, Talebi 2013) conclude the evidence is weak and inconsistent. There is a plausible mechanism if a patient has documented B6 insufficiency (the active P5P form is involved in nerve function), but routine supplementation does not produce reliable benefit. Use only at low dose, only if other measures aren't sufficient, and avoid chronic dosing above 100 mg/day.
Alpha-lipoic acid — for diabetic-associated or mixed neuropathic features
600 mg/day (R-ALA preferred), 8–12 weeks
ALA has the cleanest neuropathic-pain trial evidence in diabetic peripheral neuropathy and has been studied in CTS, particularly when combined with curcumin and gamma-linolenic acid. Small trials (Pajardi 2014, Di Geronimo 2009) show modest reductions in symptom severity scales and may improve outcomes when paired with splinting and/or after surgical release.
Curcumin (bioavailable form)
500 mg BID Meriva or BCM-95 (bioavailable curcumin); 8 weeks
Curcumin's general anti-inflammatory effect has been studied in CTS-associated inflammation. Effect is modest. Use a bioavailability-enhanced preparation (Meriva/phytosome, BCM-95, or curcumin-with-piperine) — standard turmeric powder has trivial bioavailability.
Methylcobalamin (B12) — if borderline or deficient
1000 mcg/day sublingual or oral; check serum B12 and methylmalonic acid before starting
B12 deficiency causes peripheral neuropathy that can present like or co-exist with CTS. Test if any risk factors (vegan diet, PPI use, metformin, older age, GI disease). Routine supplementation in B12-replete patients doesn't help CTS, but correcting deficiency does help neuropathic symptoms.
Vitamin D — if deficient
1000–2000 IU/day vitamin D3 to a 25-OH-D target of 30–50 ng/mL
Observational studies link low vitamin D status to CTS severity. Causation is unclear, but repletion is low-harm and reasonable in deficient patients.
What outperforms the supplement layer
- Night splinting — the single highest-yield non-pharmacological intervention. Wrist-neutral splint worn at night for 4–6 weeks reduces symptoms in 60–70% of mild-to-moderate CTS.
- Ergonomic correction — keyboard position, mouse use, wrist rest, breaks. Reduce sustained wrist flexion/extension.
- Treating underlying contributors — hypothyroidism, diabetes, rheumatoid arthritis, pregnancy-related fluid shifts, and obesity all worsen CTS. Treat the underlying condition.
- Corticosteroid injection — for moderate symptoms unresponsive to splinting. Effect is real but often temporary.
- Carpal tunnel release surgery — for severe symptoms, motor signs (thenar wasting, weakness), or refractory disease. Outcomes are excellent; supplements do not substitute.
- Tendon and nerve glides — physical therapy / occupational therapy guided exercises for mild-to-moderate disease.
What to skip
- High-dose B6 (>100 mg/day chronically) — causes the very neuropathy being treated. The "CTS megadose B6" lore is outdated.
- "Nerve repair" combination products — typically sub-therapeutic blends with marketing that doesn't match evidence.
- Glucosamine/chondroitin — these target joint cartilage, not nerve entrapment. Wrong target.
- Magnetic bracelets and "energy healing" wristbands — no evidence; not equivalent to a proper splint.
- CBD products marketed for CTS — limited trial evidence; product variability.
- "Detox" or "circulation" supplements — wrong mechanism for nerve entrapment.
What to track
The Boston Carpal Tunnel Questionnaire (Symptom Severity Scale and Functional Status Scale) is the standard. Track symptoms weekly during a 6–8 week splinting trial. Worsening numbness, weakness, or new thenar wasting deserves urgent evaluation. Nerve conduction studies are the gold standard for diagnosis severity.